Definitive Contract 140D0420C0006
Award Date
2/21/20
Potential Completion Date
5/31/23
Potential Value
$3.2M
Funding Federal Agency
Defense Advanced Research Projects Agency
Contracting Federal Agency
Interior Business Center
Awardee
Autonomous Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $3,007,557.97 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of new platform technologies for viral and therapeutic evolution assays under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a firm fixed price pricing type and a period of performance through November 2022. Autonomous Therapeutics has also...
This SBIR Phase II contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Quorum Innovations LLC, a small business located in Sarasota, Florida. The $1,249,032 Firm Fixed Price contract supports research into "Tough Self-Decontaminating Surfaces (TSDS) - Anti-Adhesive Protein for Human Respiratory Surface Defense Against Respiratory Viruses and Pathogens", with a focus on COVID-19. This research is part of DARPA's SBIR program to leverage small business...
This is a $223,201 firm fixed price STTR Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Netrias, LLC, a small business AI company. The contract is for the development of "PATHENGINE: A PLATFORM TO AUTOMATE THE INTEGRATION OF DATA TO PREDICT PATHOGENIC POTENTIAL", which aligns with DARPA's mission of advancing transformative technologies for national security. The contract was awarded under DARPA's Small Business Technology Transfer (STTR)...
This is a $45,359,554.17 cost-plus-fixed-fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Sarepta Therapeutics, Inc. for the development of a new antiviral (antisense) product. The contract was awarded on November 29, 2006 with a completion date of February 28, 2011. The contract does not have a set-aside designation. Sarepta Therapeutics, Inc. is the prime contractor, and there is no information provided about major subcontractors. The DTRA is the funding...
This federal contract award, valued at $330,136,246.14, was granted by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to 4J Therapeutics Inc., a self-certified small disadvantaged business. The contract's objective is to demonstrate the versatility and efficacy of 4J Therapeutics' programmable antiviral technology platform by assembling a preclinical package for LNA14, performing a Phase 1a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad...
This is a $1,727,615.82 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ceres Nanosciences, Inc., a small business. The contract is for SBIR (Small Business Innovation Research) Phase II work on "Application of the Nanotrap Platform for Immunome Biomarker Preservation and Monitoring." This effort supports DARPA's mission in defense and national security by developing nanotechnology-enabled products and services to advance diagnostics and...
This is a $1,140,081.00 Small Business Innovation Research (STTR) Phase II contract awarded by the Defense Threat Reduction Agency to Biological Mimetics, Inc., a biotechnology company that combines biology and engineering to identify and prevent global infections. The contract is for research and development services related to infectious diseases, vaccines, diagnostics, and therapeutics. Biological Mimetics has previously received grants and contracts from federal agencies like the National...
This is a $1,348,992.00 cost-plus-fixed-fee definitive contract awarded by the Naval Air Warfare Center (NAVAIRAWC), a defense agency, to TDA Research, Inc., a small business subchapter S corporation located in Colorado. The contract is for a Small Business Innovation Research (SBIR) Phase II research and development effort, with a focus on delivering innovative technologies to support the government's Coronavirus COVID-19 response. As an SBIR Phase II contract, this award stems from a prior...
This is a $583,435.00 firm-fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Senti Biosciences, Inc. for a Biological Technologies Office study on programmable therapeutic cell circuit platforms. The contract has a completion date of January 31, 2018 and does not have a set-aside designation. As DARPA is the Defense Department's advanced research agency, this contract is likely part of their efforts to develop novel biotechnology capabilities for...